[1]
“A Study of the Safety and Efficacy of Alternate Day vs. Daily Rosuvastatin Dosing in Hypercholesterolemia Patients at Tertiary Care Hospital”, J Nobel Med Coll, vol. 10, no. 2, pp. 33–37, Dec. 2021, doi: 10.3126/jonmc.v10i2.41768.